filmov
tv
Immunotherapy in NSCLC: exciting emerging strategies
Показать описание
03:50 Biomarkers for immune checkpoint inhibitor therapies in NSCLC: Dr. Tricia Cottrell, Assistant Professor, Queen’s University, Canada
26:35 Using AI to predict immune checkpoint inhibitors efficacy in NSCLC: Dr. David Kwiatkowski, Professor of Medicine, Brigham and Women's Hospital, USA
47:26 NSCLC clinical trials: Immunotherapy combination approaches: Dr. Rajat Thawani, Assistant Professor, University of Chicago, USA
26:35 Using AI to predict immune checkpoint inhibitors efficacy in NSCLC: Dr. David Kwiatkowski, Professor of Medicine, Brigham and Women's Hospital, USA
47:26 NSCLC clinical trials: Immunotherapy combination approaches: Dr. Rajat Thawani, Assistant Professor, University of Chicago, USA
1:01:39
0:33:24
0:04:55
0:20:48
0:05:42
0:19:27
1:19:33
0:00:33
0:01:02
0:02:07
0:50:51
0:45:12
0:16:27
1:08:56
0:02:41
0:08:37
0:04:05
0:01:47
0:32:52
0:00:58
0:36:18
0:06:24
0:05:22
0:02:22